Table 1 Characteristics of subjects

Age in years (median, range)

59, 55-64

Gender (women/men)

2/5

Disease duration (median, range)

5, 2-14

MSA Type (cerebellar/parkinsonian)

5/2

Levodopa (number of patients)

3

Amantadine (number of patients)

3

Proamatine (number of patients)

3

Fludrocortisone (number of patients)

2

Pyridostigmine (number of patients)

2